These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 7966386)
1. Mutagen hypersensitivity as a biomarker of genetic predisposition to carcinogenesis. Olden K J Natl Cancer Inst; 1994 Nov; 86(22):1660-1. PubMed ID: 7966386 [No Abstract] [Full Text] [Related]
5. Molecular epidemiology of human cancer: biomarkers of genotoxic exposure and susceptibility. Grant SG J Environ Pathol Toxicol Oncol; 2001; 20(4):245-61. PubMed ID: 11797834 [TBL] [Abstract][Full Text] [Related]
6. Endogenous carcinogenesis: molecular oncology into the twenty-first century--presidential address. Loeb LA Cancer Res; 1989 Oct; 49(20):5489-96. PubMed ID: 2676144 [No Abstract] [Full Text] [Related]
7. Nature and nurture - lessons from chemical carcinogenesis. Luch A Nat Rev Cancer; 2005 Feb; 5(2):113-25. PubMed ID: 15660110 [TBL] [Abstract][Full Text] [Related]
8. Gender-related differences in response to mutagens and carcinogens. Kirsch-Volders M; Bonassi S; Herceg Z; Hirvonen A; Möller L; Phillips DH Mutagenesis; 2010 May; 25(3):213-21. PubMed ID: 20194421 [TBL] [Abstract][Full Text] [Related]
9. Genetic predisposition to cancer with special reference to mutagen sensitivity. Hsu TC In Vitro Cell Dev Biol; 1987 Sep; 23(9):591-603. PubMed ID: 3308827 [TBL] [Abstract][Full Text] [Related]
10. Human somatic mutation assays as biomarkers of carcinogenesis. Compton PJ; Hooper K; Smith MT Environ Health Perspect; 1991 Aug; 94():135-41. PubMed ID: 1954924 [TBL] [Abstract][Full Text] [Related]
11. Xeroderma pigmentosum and the role of DNA repair in oncogenesis. Giannelli F Bull Cancer; 1978; 65(3):323-34. PubMed ID: 719184 [TBL] [Abstract][Full Text] [Related]
12. Mutagen sensitivity has high heritability: evidence from a twin study. Wu X; Spitz MR; Amos CI; Lin J; Shao L; Gu J; de Andrade M; Benowitz NL; Shields PG; Swan GE Cancer Res; 2006 Jun; 66(12):5993-6. PubMed ID: 16778168 [TBL] [Abstract][Full Text] [Related]
14. Risk factors for cancer. Lyman GH Prim Care; 1992 Sep; 19(3):465-79. PubMed ID: 1410059 [TBL] [Abstract][Full Text] [Related]
15. Tumor heterogeneity: the Lernaean hydra of oncology? Janiszewska M; Beca F; Polyak K Oncology (Williston Park); 2014 Sep; 28(9):781-2, 784. PubMed ID: 25224477 [No Abstract] [Full Text] [Related]
16. Tumor heterogeneity and implications for clinical practice. Chu E Oncology (Williston Park); 2014 Sep; 28(9):726, 741. PubMed ID: 25224470 [No Abstract] [Full Text] [Related]
17. Tumor heterogeneity is fundamental to the tumor ecosystem. Heppner GH; Shekhar M Oncology (Williston Park); 2014 Sep; 28(9):780-1. PubMed ID: 25224476 [No Abstract] [Full Text] [Related]
18. Environmental and chemical carcinogenesis. Wogan GN; Hecht SS; Felton JS; Conney AH; Loeb LA Semin Cancer Biol; 2004 Dec; 14(6):473-86. PubMed ID: 15489140 [TBL] [Abstract][Full Text] [Related]
19. Induced genome instability as a potential screening test for cancer susceptibility? Shadan FF; Koziol J Med Hypotheses; 2000 Jul; 55(1):69-72. PubMed ID: 11021331 [TBL] [Abstract][Full Text] [Related]
20. [The mitochondrial theory of carcinogenesis]. Zotin AI Izv Akad Nauk SSSR Biol; 1991; (6):805-15. PubMed ID: 1809780 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]